Dr Megan Cully
Research Commercialisation Manager since 2025.
Previously
Scientific Director, Marker AG [2023-2025]
Associate, Deep Science Ventures [2022-2023]
Editor/Senior Editor, News Writer, Nature Reviews Drug Discovery [2014-2022]
Associate Editor, Nature Reviews Cardiology, Nature Reviews Rheumatology [2012-2014]
Post-doctoral Fellow, Cancer Research UK London Research Institute [2005-2009]
PhD, Medical Biophysics, University of Toronto [2000-2005]
BSc, Biochemistry, University of Calgary [1995-1999]